AngioInsight offers a transformative AI-driven solution for real-time, non-invasive assessment of stenosis and Fractional Flow Reserve (FFR). Our technology delivers rapid, accurate data on flow dynamics and anatomy, aiding in the detection of microvascular disease. With an automated, streamlined workflow, AngioInsight integrates AI diagnostics efficiently, ensuring precision and reliability in cardiovascular care.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 601 Carlson Parkway,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.angioinsight.com/
- Keywords
- Coronary Disease Diagnosis, Machine Learning, Computational Fluid Dynamics, Angiography, Image Processing.
- HQ
- Minnetonka, Minnesota
Angioinsight Questions
Angioinsight's website is https://www.angioinsight.com/
Angioinsight's LinkedIn profile is https://www.linkedin.com/company/angioinsight
Angioinsight has
16 employees.
View email and phone details for 16
employees at Angioinsight.
Angioinsight's industry is
Biotechnology Research
Angioinsight's top competitors are
Arborsense, Inc.,
Elucid,
M3d,
Corvista® Health,
Heartflow,
Cleerly,
Angiodynamics,
Medtronic,
Viz.ai,
Ambra Health.
Angioinsight's categories are Biotechnology Research
Angioinsight's founding year is 2018
